Women's Health
Mithra sells position in Mayne Pharma to free up cash
Women’s health company Mithra has sold all its shares in Mayne Pharma for €12.8m ($13.7m), a week after the former…
Mithra sets out plan to rescue cash runway
Mithra Pharmaceuticals has revealed its next courses of action as the women’s health company looks to secure its cash flow…
Astellas seeks approval for Padcev-Keytruda combo therapy in Japan
Astellas Pharma has submitted a supplemental new drug application (sNDA) in Japan seeking approval for the combination of Padcev (enfortumab…
Atossa Therapeutics progresses Phase II preventative breast cancer therapy
Atossa Therapeutics estimates a Q3 readout of a Phase II trial that studies the company’s lead asset z-endoxifen, says CEO…
HHS announces 2024 actions to protect contraceptive care
Following the 51st anniversary of Roe v. Wade on 22 January, the US Department for Health and Human Services (HHS)…
Comanche raises $75m to develop preeclampsia therapy
US-based Comanche Biopharma has raised $75m in an oversubscribed Series B financing round to develop its small interfering RNA (siRNA)…
TiumBio raises $12m to advance clinical pipeline development
South Korean TiumBio has raised KRW20bn ($12m) through stock financing to fund the development of its clinical programmes. The capital…
BioNTech-DualityBio’s endometrial cancer ADC gains breakthrough status
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation for BioNTech and Duality Biologics’ (DualityBio) antibody-drug conjugate (ADC)…
Aditxt acquires Phexxi contraceptive gel-maker Evofem for $100m
US-based biotech Aditxt is venturing into the women’s health market after it acquired Evofem Biosciences in a deal worth approximately…
Freya Biosciences secures $38m to develop reproductive immunotherapies
Denmark-based Freya Biosciences has secured $38m in a Series A funding round to progress the development of women’s reproductive immunotherapies. …
